Answers are grounded in this paper and cite their sources.
Because apolipoprotein-A2 (ApoA2), a key component of high-density lipoprotein cholesterol (HDL-C), lacks clear clinical significance, we investigated its impact on cardiovascular events in patients undergoing percutaneous coronary intervention (PCI).
No takes yet. Share an insight, caveat, or question.
Akiyama et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: